| Application number | Title of the application | Filing Date | Status |
|---|
| 08/229767 | AQUEOUS AGENT | Apr 18, 1994 | Abandoned |
| 08/222552 | INHIBITORS OF CATHEPSIN G AND ELASTASE FOR PREVENTING CONNECTIVE TISSUE DEGRADATION | Apr 3, 1994 | Abandoned |
Array
(
[id] => 3412513
[patent_doc_number] => 05461143
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-10-24
[patent_title] => 'Oligosaccharide enzyme substrates and inhibitors: methods and compositions'
[patent_app_type] => 1
[patent_app_number] => 8/219242
[patent_app_country] => US
[patent_app_date] => 1994-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 39317
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 457
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/461/05461143.pdf
[firstpage_image] =>[orig_patent_app_number] => 219242
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/219242 | Oligosaccharide enzyme substrates and inhibitors: methods and compositions | Mar 28, 1994 | Issued |
Array
(
[id] => 3519612
[patent_doc_number] => 05529986
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-25
[patent_title] => 'Conjugate, its preparation and use and a substrate prepared with the conjugate'
[patent_app_type] => 1
[patent_app_number] => 8/211224
[patent_app_country] => US
[patent_app_date] => 1994-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7493
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/529/05529986.pdf
[firstpage_image] =>[orig_patent_app_number] => 211224
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/211224 | Conjugate, its preparation and use and a substrate prepared with the conjugate | Mar 24, 1994 | Issued |
Array
(
[id] => 3731069
[patent_doc_number] => 05693625
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-02
[patent_title] => 'Method of regenerating cells and tissues using functionalized dextrans'
[patent_app_type] => 1
[patent_app_number] => 8/216859
[patent_app_country] => US
[patent_app_date] => 1994-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6808
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/693/05693625.pdf
[firstpage_image] =>[orig_patent_app_number] => 216859
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/216859 | Method of regenerating cells and tissues using functionalized dextrans | Mar 23, 1994 | Issued |
Array
(
[id] => 4241168
[patent_doc_number] => 06090928
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-18
[patent_title] => 'Process for the preparation and work-up of N-hydroxyalkylchitosans soluble in aqueous medium'
[patent_app_type] => 1
[patent_app_number] => 8/217189
[patent_app_country] => US
[patent_app_date] => 1994-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3098
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/090/06090928.pdf
[firstpage_image] =>[orig_patent_app_number] => 217189
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/217189 | Process for the preparation and work-up of N-hydroxyalkylchitosans soluble in aqueous medium | Mar 23, 1994 | Issued |
Array
(
[id] => 3426047
[patent_doc_number] => 05459249
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-10-17
[patent_title] => 'Process for continuous manufacture of alkylglycosides'
[patent_app_type] => 1
[patent_app_number] => 8/214630
[patent_app_country] => US
[patent_app_date] => 1994-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3665
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/459/05459249.pdf
[firstpage_image] =>[orig_patent_app_number] => 214630
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/214630 | Process for continuous manufacture of alkylglycosides | Mar 17, 1994 | Issued |
Array
(
[id] => 3116743
[patent_doc_number] => 05410039
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-04-25
[patent_title] => 'Process for the synthesis of glycosaminoglycans containing .alpha.-L-galacturonic acid substituted with nucleophilic groups in position 3'
[patent_app_type] => 1
[patent_app_number] => 8/207140
[patent_app_country] => US
[patent_app_date] => 1994-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2675
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 407
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/410/05410039.pdf
[firstpage_image] =>[orig_patent_app_number] => 207140
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/207140 | Process for the synthesis of glycosaminoglycans containing .alpha.-L-galacturonic acid substituted with nucleophilic groups in position 3 | Mar 6, 1994 | Issued |
Array
(
[id] => 3482817
[patent_doc_number] => 05405949
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-04-11
[patent_title] => 'Process for the synthesis of glycosaminoglycans with heparin or heparan structure modified in position 2 of the .alpha.-L-iduronic-2-O-sulfate acid'
[patent_app_type] => 1
[patent_app_number] => 8/206980
[patent_app_country] => US
[patent_app_date] => 1994-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2678
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 391
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/405/05405949.pdf
[firstpage_image] =>[orig_patent_app_number] => 206980
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/206980 | Process for the synthesis of glycosaminoglycans with heparin or heparan structure modified in position 2 of the .alpha.-L-iduronic-2-O-sulfate acid | Mar 6, 1994 | Issued |
Array
(
[id] => 3684367
[patent_doc_number] => 05633357
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-27
[patent_title] => 'Synthesis of carboxylic acid glucuronides'
[patent_app_type] => 1
[patent_app_number] => 8/206019
[patent_app_country] => US
[patent_app_date] => 1994-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22853
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/633/05633357.pdf
[firstpage_image] =>[orig_patent_app_number] => 206019
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/206019 | Synthesis of carboxylic acid glucuronides | Mar 3, 1994 | Issued |
Array
(
[id] => 3505867
[patent_doc_number] => 05514668
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-07
[patent_title] => 'Composition for removing or inactivating harmful components in blood or other extracellular body fluids'
[patent_app_type] => 1
[patent_app_number] => 8/205629
[patent_app_country] => US
[patent_app_date] => 1994-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5974
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/514/05514668.pdf
[firstpage_image] =>[orig_patent_app_number] => 205629
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/205629 | Composition for removing or inactivating harmful components in blood or other extracellular body fluids | Mar 3, 1994 | Issued |
| 08/204515 | METHOD FOR TREATING AND INHIBITING GASTRIC AND DUODENAL ULCERS | Mar 1, 1994 | Abandoned |
Array
(
[id] => 3550510
[patent_doc_number] => 05547944
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-20
[patent_title] => 'Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it'
[patent_app_type] => 1
[patent_app_number] => 8/199229
[patent_app_country] => US
[patent_app_date] => 1994-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4761
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/547/05547944.pdf
[firstpage_image] =>[orig_patent_app_number] => 199229
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/199229 | Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it | Feb 22, 1994 | Issued |
| 08/199523 | METHOD FOR SOLUBILIZING DRUGS | Feb 21, 1994 | Abandoned |
| 08/197459 | PHARMACEUTICAL AND DIETARY COMPOSITION | Feb 15, 1994 | Abandoned |
| 08/192833 | LIPID-FREE POLYSACCHARIDE COMPOUND, PREPARATION PROCESS, COMPOSITIONS CONTAINING IT | Feb 6, 1994 | Abandoned |
Array
(
[id] => 3102826
[patent_doc_number] => 05447917
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-09-05
[patent_title] => 'D-tagatose as anti-hyperglycemic agent'
[patent_app_type] => 1
[patent_app_number] => 8/190938
[patent_app_country] => US
[patent_app_date] => 1994-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1760
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/447/05447917.pdf
[firstpage_image] =>[orig_patent_app_number] => 190938
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/190938 | D-tagatose as anti-hyperglycemic agent | Feb 2, 1994 | Issued |
| 08/190820 | HEPARIN FRACTION WITH ANTI-HIV ACTIVITY | Feb 1, 1994 | Abandoned |
| 08/188867 | ORGANOSILICON COMPOUNDS CONTAINING GLYCOSIDE RADICALS AND PROCESSES FOR THEIR PREPARATION | Jan 30, 1994 | Abandoned |
Array
(
[id] => 3411985
[patent_doc_number] => 05438133
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-08-01
[patent_title] => 'Cyclodextrin catenane compounds capable of forming inclusion complexes'
[patent_app_type] => 1
[patent_app_number] => 8/190010
[patent_app_country] => US
[patent_app_date] => 1994-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7094
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/438/05438133.pdf
[firstpage_image] =>[orig_patent_app_number] => 190010
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/190010 | Cyclodextrin catenane compounds capable of forming inclusion complexes | Jan 26, 1994 | Issued |